Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-28

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter Healthcare Corporation's supplemental application for naloxone hydrochloride, a generic opioid overdose reversal agent, under the approved A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)